Table 5 Adverse events occurring in at least 5% of patients in either treatment group
pAT (N = 113) | AT gamma (N = 108) | |||
|---|---|---|---|---|
Number of patients (%) | Number of events | Number of patients (%) | Number of events | |
Erythema | 12 (10.6) | 14 | 18 (16.7) | 19 |
Diarrhea | 6 (5.3) | 6 | 17 (15.7) | 18 |
Decubitus ulcer | 10 (8.8) | 12 | 12 (11.1) | 13 |
Pneumonia | 6 (5.3) | 6 | 10 (9.3) | 10 |
Vomiting | 7 (6.2) | 8 | 9 (8.3) | 11 |
Constipation | 4 (3.5) | 5 | 9 (8.3) | 9 |
Insomnia | 10 (8.8) | 10 | 9 (8.3) | 9 |
Anemia | 8 (7.1) | 9 | 7 (6.5) | 7 |
Sepsis | 8 (7.1) | 8 | 6 (5.6) | 6 |
Hypokalemia | 9 (8.0) | 9 | 5 (4.6) | 7 |
Hypernatremia | 6 (5.3) | 6 | 4 (3.7) | 4 |
Pleural effusion | 8 (7.1) | 8 | 4 (3.7) | 4 |
Nausea | 7 (6.2) | 7 | 3 (2.8) | 4 |
Hepatic function abnormal | 6 (5.3) | 6 | 3 (2.8) | 3 |
Blood bilirubin increased | 6 (5.3) | 6 | 3 (2.8) | 3 |
Delirium | 6 (5.3) | 6 | 3 (2.8) | 3 |
Skin exfoliation | 11 (9.7) | 17 | 3 (2.8) | 3 |